サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426390

侵襲性真菌感染症の世界市場レポート 2024

Invasive Fungal Infections Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
侵襲性真菌感染症の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

侵襲性真菌感染症の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.6%の年間複合成長率（CAGR）で90億8,000万米ドルに成長すると予想されます。予測期間の成長は、世界の健康への備え、公衆衛生教育、新規抗真菌剤の開発、気候変動の影響、および学際的なアプローチに起因すると考えられます。予測期間の主な動向には、診断技術の進歩、オーダーメイドの治療アプローチ、患者中心のケア、抗真菌薬の併用療法、医薬品開発の協力などが含まれます。

ヒト免疫不全ウイルス（HIV）に苦しむ人口の予想される増加により、今後数年間で侵襲性真菌感染症市場の拡大が促進されると予想されます。 HIVは、病気や感染症と闘う免疫系の能力を損なうウイルスです。 HIVやAIDSの影響を受ける人を含め、免疫系が低下している人の数が増加するにつれて、侵襲性真菌感染症に対する感受性が高まります。この急増により、メーカーは専門的でより効果的な抗真菌薬を開発し、供給する機会が生まれます。 2023年 7月の国連 HIV/エイズ共同計画（UNAIDS）によると、世界のHIV感染者数は2022年には3,900万人に増加し、2020年の3,770万人から3.17%増加しました。さらに、約130万人の新規 HIV感染者が発生しています。したがって、HIVに罹患する人口の予想される増加は、侵襲性真菌感染症市場の成長を促進すると予想されます。

がん患者数の増加は、将来侵襲性真菌感染症市場の拡大を促進すると予測されています。 侵襲性真菌感染症（IFI）は、がん患者、特に免疫力が低下している患者にとって、重篤で潜在的に生命を脅かす合併症を引き起こします。がん生存者の人口の増加は、これらの人々におけるIFIのリスク増加に寄与する重要な要因です。 2022年 11月に国立がん研究所が報告したように、2040年までにがん生存者は約2,600万人になると予測されています。さらに、がんと診断されてから5年以上生存する人の数は30%近く急増し、その後10年間で1,630万人に達すると予想されています。その結果、がん患者と生存者の数の増加が侵襲性真菌感染症市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の侵襲性真菌感染症市場、疾患タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • カンジダエミと浸潤性カンジダ症
  • 腹腔内カンジダ症
  • クリプトコッカス髄膜炎
  • 食道カンジダ症
  • ヒストプラズマ症急性肺
  • その他
  • 世界の侵襲性真菌感染症市場、薬剤タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ポリエン
  • トリアゾール
  • エキノカンジン
  • フルシトシン
  • その他
  • 世界の侵入性真菌感染症市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 在宅ケア
  • 専門クリニック
  • その他

第7章 地域および国の分析

  • 世界の侵襲性真菌感染症市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の侵襲性真菌感染症市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 侵襲性真菌感染症市場の競合情勢
  • 侵襲性真菌感染症市場の企業プロファイル
    • Pfizer Inc.
    • Merck And Co. Inc.
    • Bayer AG
    • Abbott Laboratories
    • GSK plc

第31章 その他の大手および革新的な企業

  • Gilead Sciences Inc.
  • Siemens Healthineers
  • Mylan NV
  • Astellas Pharma Inc.
  • Quest Diagnostics Incorporated
  • Sun Pharmaceutical Industries Ltd.
  • BioMerieux SA
  • BioMarin Pharmaceutical Inc.
  • Xellia Pharmaceuticals
  • Basilea Pharmaceutica
  • Cidara Therapeutic Inc.
  • Pulmocide Ltd.
  • NovaBiotics Ltd
  • F2G Ltd.
  • Giner Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13402

Invasive fungal infections are severe diseases caused by pathogenic fungi that penetrate and spread within the body, extending beyond the point of initial infection. These infections involve the penetration of fungal organisms into deeper layers of tissue, including the bloodstream, organs, or other body structures. The treatment of invasive fungal infections typically includes the use of antifungal medications and, in certain instances, surgical procedures to excise infected tissue.

The main types of invasive fungal infections encompass candidemia and invasive candidiasis, intraabdominal candidiasis, cryptococcal meningitis, esophageal candidiasis, histoplasmosis acute pulmonary, and others. Candidemia and invasive candidiasis, for instance, are infections caused by Candida fungus that can affect various parts of the body, including the blood, heart, brain, eyes, bones, or other organs. Treatment involves the use of different drug types, such as polyenes, triazoles, echinocandins, flucytosine, and others, and is administered by various end-users, including hospitals, homecare, specialty clinics, and others.

The invasive fungal infections market research report is one of a series of new reports from The Business Research Company that provides invasive fungal infections market statistics, including invasive fungal infections industry global market size, regional shares, competitors with a invasive fungal infections market share, detailed invasive fungal infections market segments, market trends and opportunities, and any further data you may need to thrive in the invasive fungal infections industry. This invasive fungal infections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The invasive fungal infections market size has grown strongly in recent years. It will grow from $7.21 billion in 2023 to $7.58 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to the global spread of infections, hematopoietic stem cell transplants, an aging population, hospital-acquired infections, and environmental factors.

The invasive fungal infections market size is expected to see steady growth in the next few years. It will grow to $9.08 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to global health preparedness, public health education, the development of novel antifungal agents, the impact of climate change, and multidisciplinary approaches. Major trends in the forecast period include advancements in diagnostic technologies, tailored therapeutic approaches, patient-centric care, combination antifungal therapies, and collaborations for drug development.

The projected increase in the population afflicted by Human Immunodeficiency Virus (HIV) is anticipated to propel the expansion of the invasive fungal infection market in the coming years. HIV is a virus that compromises the immune system's ability to combat diseases and infections. As the number of individuals with compromised immune systems, including those affected by HIV or AIDS, rises, susceptibility to invasive fungal infections escalates. This surge creates opportunities for manufacturers to develop and supply specialized and more effective antifungal drugs. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS) in July 2023, the global population living with HIV increased to 39 million in 2022, marking a 3.17% rise from 37.7 million in 2020. Additionally, approximately 1.3 million new HIV infections were reported in 2022. Hence, the anticipated rise in the population affected by HIV is expected to drive the growth of the invasive fungal infection market.

The mounting number of cancer patients is forecasted to fuel the expansion of the invasive fungal infections market in the future. Invasive fungal infections (IFIs) pose severe and potentially life-threatening complications for cancer patients, particularly those with weakened immune systems. The growing population of cancer survivors is a significant factor contributing to the increased risk of IFIs among these individuals. As reported by the National Cancer Institute in November 2022, it is projected that by 2040, there will be approximately 26.0 million cancer survivors. Furthermore, the number of individuals who have survived five or more years after a cancer diagnosis is expected to surge by nearly 30%, reaching 16.3 million over the subsequent decade. Consequently, the escalating number of cancer patients and survivors stands as a driving force behind the growth of the invasive fungal infections market.

The emergence of drug-resistant fungal strains represents a notable challenge that may impede the growth of the invasive fungal infection market during the forecast period. The appearance of these resistant strains poses a substantial hurdle in the treatment of invasive fungal infections. With evolving defenses that enable survival against modern medicines, these strains compromise the efficacy of antifungal drugs, complicating the treatment of patients affected by such infections. For instance, as reported by CIDRAP (Center for Infectious Disease Research and Policy) in March 2023, there was a concerning 95% increase in Candida auris followed by a 59% rise in 2020. This spike in drug-resistant fungal strains highlights a significant obstacle and contributes to hindering the growth trajectory of the invasive fungal infection market.

Prominent companies operating within the invasive fungal infection market are dedicated to developing advanced antifungal drugs, such as Posaconazole, to meet the escalating demand for more effective and innovative treatments for fungal infections, aiming to attain a competitive advantage in the market. Antifungal medications such as Posaconazole are specifically designed to combat fungal infections by either inhibiting their growth or eradicating the fungi responsible for the infection. For instance, in June 2021, Cadila Pharmaceuticals Ltd., a renowned pharmaceutical company based in India, introduced Posaconazole, a novel triazole antifungal drug. This drug demonstrates efficacy against various invasive fungal diseases and is recommended as a secondary treatment for mucormycosis (black fungus). Approved for preventing aspergillus and candida infections in immunocompromised patients, as well as for treating oropharyngeal candidiasis (OPC), Posaconazole represents an innovative addition to the arsenal of treatments available for these fungal infections.

In April 2021, Pfizer Inc., a prominent US-based pharmaceutical company, completed the acquisition of Amplyx Pharmaceuticals, Inc. for an undisclosed sum. This strategic acquisition marks Pfizer's expansion in the realm of infectious diseases and anti-infectives by incorporating a promising Phase 2 antifungal candidate, Fosmanogepix (APX001), specifically developed for the treatment of invasive fungal infections. Amplyx Pharmaceuticals, Inc., a US-based pharmaceutical company renowned for its focus on pioneering therapies targeting life-threatening diseases, notably invasive fungal infections, provided Pfizer with this innovative antifungal candidate as part of the acquisition.

Major companies operating in the invasive fungal infections market report are Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK plc, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMerieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd, F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB

North America was the largest region in the invasive fungal infections market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the invasive fungal infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The invasive fungal infections market consists of revenues earned by entities by providing services such as diagnostic testing, clinical research and development, educational programs, and awareness campaign services. The market value includes the value of related goods sold by the service provider or included within the service offering. The invasive fungal infections market also includes sales of azoles, allylamines, and morpholines, which are used in treating invasive fungal infections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Invasive Fungal Infections Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on invasive fungal infections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for invasive fungal infections? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The invasive fungal infections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Disease Type: Candidaemi And Invasive Candidiasis; Intra Abdominal Candidiasis; Cryptococcal Meningitis; Esophageal Candidiasis; Histoplasmosis Acute Pulmonary; Other Disease Type
  • 2) By Drug Type: Polyenes; Triazoles; Echinocandins; Flucytosine; Other Drug Type
  • 3) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Merck And Co. Inc.; Bayer AG; Abbott Laboratories; GSK plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Invasive Fungal Infections Market Characteristics

3. Invasive Fungal Infections Market Trends And Strategies

4. Invasive Fungal Infections Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Invasive Fungal Infections Market Size and Growth

  • 5.1. Global Invasive Fungal Infections Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Invasive Fungal Infections Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Invasive Fungal Infections Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Invasive Fungal Infections Market Segmentation

  • 6.1. Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Candidaemi And Invasive Candiasis
  • Intra Abdominal Candiasis
  • Cryptococcal Meningitis
  • Esophageal Candidiasis
  • Histoplasmosis Acute Pulmonary
  • Other Disease Types
  • 6.2. Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polyenes
  • Triazoles
  • Echinocandins
  • Flucytosine
  • Other Drug Types
  • 6.3. Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users

7. Invasive Fungal Infections Market Regional And Country Analysis

  • 7.1. Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Invasive Fungal Infections Market

  • 8.1. Asia-Pacific Invasive Fungal Infections Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Invasive Fungal Infections Market

  • 9.1. China Invasive Fungal Infections Market Overview
  • 9.2. China Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Invasive Fungal Infections Market

  • 10.1. India Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Invasive Fungal Infections Market

  • 11.1. Japan Invasive Fungal Infections Market Overview
  • 11.2. Japan Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Invasive Fungal Infections Market

  • 12.1. Australia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Invasive Fungal Infections Market

  • 13.1. Indonesia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Invasive Fungal Infections Market

  • 14.1. South Korea Invasive Fungal Infections Market Overview
  • 14.2. South Korea Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Invasive Fungal Infections Market

  • 15.1. Western Europe Invasive Fungal Infections Market Overview
  • 15.2. Western Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Invasive Fungal Infections Market

  • 16.1. UK Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Invasive Fungal Infections Market

  • 17.1. Germany Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Invasive Fungal Infections Market

  • 18.5. France Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Invasive Fungal Infections Market

  • 19.9. Italy Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Invasive Fungal Infections Market

  • 20.13. Spain Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Invasive Fungal Infections Market

  • 21.1. Eastern Europe Invasive Fungal Infections Market Overview
  • 21.2. Eastern Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Invasive Fungal Infections Market

  • 22.1. Russia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Invasive Fungal Infections Market

  • 23.1. North America Invasive Fungal Infections Market Overview
  • 23.2. North America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Invasive Fungal Infections Market

  • 24.1. USA Invasive Fungal Infections Market Overview
  • 24.2. USA Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Invasive Fungal Infections Market

  • 25.1. Canada Invasive Fungal Infections Market Overview
  • 25.2. Canada Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Invasive Fungal Infections Market

  • 26.1. South America Invasive Fungal Infections Market Overview
  • 26.2. South America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Invasive Fungal Infections Market

  • 27.1. Brazil Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Invasive Fungal Infections Market

  • 28.1. Middle East Invasive Fungal Infections Market Overview
  • 28.2. Middle East Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Invasive Fungal Infections Market

  • 29.1. Africa Invasive Fungal Infections Market Overview
  • 29.2. Africa Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Invasive Fungal Infections Market Competitive Landscape And Company Profiles

  • 30.1. Invasive Fungal Infections Market Competitive Landscape
  • 30.2. Invasive Fungal Infections Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck And Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GSK plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Invasive Fungal Infections Market Other Major And Innovative Companies

  • 31.1. Gilead Sciences Inc.
  • 31.2. Siemens Healthineers
  • 31.3. Mylan N.V.
  • 31.4. Astellas Pharma Inc.
  • 31.5. Quest Diagnostics Incorporated
  • 31.6. Sun Pharmaceutical Industries Ltd.
  • 31.7. BioMerieux SA
  • 31.8. BioMarin Pharmaceutical Inc.
  • 31.9. Xellia Pharmaceuticals
  • 31.10. Basilea Pharmaceutica
  • 31.11. Cidara Therapeutic Inc.
  • 31.12. Pulmocide Ltd.
  • 31.13. NovaBiotics Ltd
  • 31.14. F2G Ltd.
  • 31.15. Giner Inc.

32. Global Invasive Fungal Infections Market Competitive Benchmarking

33. Global Invasive Fungal Infections Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Invasive Fungal Infections Market

35. Invasive Fungal Infections Market Future Outlook and Potential Analysis

  • 35.1 Invasive Fungal Infections Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Invasive Fungal Infections Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Invasive Fungal Infections Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer